$1.06
0[0.00%]
Last update: 8:27AM Get Real Time Here
Adaptimmune Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Adaptimmune Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/10/2024 | AM | ADAP | Q1 | $0.00 | -$0.10 | — | — | $47.60M | $5.63M | — | — | Get Alert |
03/06/2024 | AM | ADAP | Q4 | -$0.18 | -$0.10 | -$0.24 | -140.00% | $11.03M | $20.47M | $231.00K | -98.87% | Get Alert |
11/08/2023 | AM | ADAP | Q3 | -$0.24 | -$0.15 | -$0.18 | -20.00% | $7.01M | $10.28M | $7.32M | -28.80% | Get Alert |
08/09/2023 | AM | ADAP | Q2 | -$0.05 | -$0.13 | -$0.12 | 7.69% | $5.54M | $8.78M | $5.13M | -41.57% | Get Alert |
05/12/2023 | AM | ADAP | Q1 | -$0.05 | -$0.14 | $0.00 | 100.00% | $3.58M | $4.93M | $47.60M | 865.54% | Get Alert |
03/06/2023 | AM | ADAP | Q4 | -$0.04 | -$0.25 | -$0.18 | 28.00% | $1.42M | $4.12M | $11.03M | 167.67% | Get Alert |
11/08/2022 | AM | ADAP | Q3 | -$0.30 | -$0.24 | -$0.24 | 0.00% | $1.20M | $4.04M | $7.01M | 73.44% | Get Alert |
08/04/2022 | AM | ADAP | Q2 | -$0.24 | -$0.25 | -$0.28 | -12.00% | $3.10M | $6.00M | $5.54M | -7.70% | Get Alert |
05/09/2022 | AM | ADAP | Q1 | -$0.04 | -$0.22 | -$0.32 | -45.45% | $434.00K | $3.29M | $3.58M | 8.66% | Get Alert |
03/14/2022 | AM | ADAP | Q4 | -$0.24 | $0.14 | -$0.25 | -278.57% | $1.50M | $96.45M | $1.42M | -98.53% | Get Alert |
11/04/2021 | AM | ADAP | Q3 | -$0.24 | -$0.26 | -$0.30 | -15.38% | $1.19M | $1.37M | $1.20M | -12.19% | Get Alert |
08/09/2021 | PM | ADAP | Q2 | -$0.24 | -$0.24 | -$0.24 | 0.00% | $502.00K | $1.36M | $3.10M | 127.57% | Get Alert |
05/06/2021 | AM | ADAP | Q1 | -$0.04 | -$0.25 | -$0.24 | 4.00% | $761.00K | $1.83M | $434.00K | -76.28% | Get Alert |
02/25/2021 | AM | ADAP | Q4 | -$0.05 | -$0.23 | -$0.24 | -4.35% | $728.00K | $1.98M | $1.50M | -24.14% | Get Alert |
11/05/2020 | AM | ADAP | Q3 | -$0.06 | -$0.25 | -$0.24 | 4.00% | $237.00K | $870.00K | $1.19M | 37.13% | Get Alert |
08/06/2020 | AM | ADAP | Q2 | -$0.07 | -$0.23 | -$0.24 | -4.35% | $157.00K | $930.00K | $502.00K | -46.02% | Get Alert |
05/14/2020 | AM | ADAP | Q1 | -$0.04 | -$0.25 | -$0.04 | 84.00% | $0.00 | $23.29M | $761.00K | -96.73% | Get Alert |
02/27/2020 | AM | ADAP | Q4 | $0.01 | -$0.32 | -$0.05 | 84.38% | $40.79M | $1.52M | $728.00K | -52.11% | Get Alert |
11/06/2019 | AM | ADAP | Q3 | $0.01 | -$0.31 | -$0.06 | 80.65% | $40.79M | $1.48M | $237.00K | -83.99% | Get Alert |
Adaptimmune Therapeutics (ADAP) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on March 6, 2024 for Q4.
The Actual EPS was $-0.24, which missed the estimate of $-0.10.
The Actual Revenue was $231K, which missed the estimate of $20.5M.
Browse earnings estimates, EPS, and revenue on all stocks.